Florida Senate - 2025 CS for SB 1360 By the Committee on Criminal Justice; and Senator Leek 591-02560-25 20251360c1 1 A bill to be entitled 2 An act relating to controlled substances; amending s. 3 893.03, F.S.; excepting from the Schedule I controlled 4 substance xylazine drug products approved by the 5 United States Food and Drug Administration for certain 6 use; amending s. 893.13, F.S.; providing criminal 7 penalties and requiring a mandatory minimum term of 8 imprisonment if a person sells, manufactures, or 9 delivers or possesses with intent to sell, 10 manufacture, or deliver xylazine; amending s. 893.135, 11 F.S.; creating the offense of trafficking in xylazine; 12 providing criminal penalties and requiring a mandatory 13 minimum term of imprisonment and fines based on the 14 quantity of the controlled substance involved in the 15 offense; providing an effective date. 16 17 Be It Enacted by the Legislature of the State of Florida: 18 19 Section 1.Paragraph (c) of subsection (1) of section 20 893.03, Florida Statutes, is amended to read: 21 893.03Standards and schedules.The substances enumerated 22 in this section are controlled by this chapter. The controlled 23 substances listed or to be listed in Schedules I, II, III, IV, 24 and V are included by whatever official, common, usual, 25 chemical, trade name, or class designated. The provisions of 26 this section shall not be construed to include within any of the 27 schedules contained in this section any excluded drugs listed 28 within the purview of 21 C.F.R. s. 1308.22, styled Excluded 29 Substances; 21 C.F.R. s. 1308.24, styled Exempt Chemical 30 Preparations; 21 C.F.R. s. 1308.32, styled Exempted 31 Prescription Products; or 21 C.F.R. s. 1308.34, styled Exempt 32 Anabolic Steroid Products. 33 (1)SCHEDULE I.A substance in Schedule I has a high 34 potential for abuse and has no currently accepted medical use in 35 treatment in the United States and in its use under medical 36 supervision does not meet accepted safety standards. The 37 following substances are controlled in Schedule I: 38 (c)Unless specifically excepted or unless listed in 39 another schedule, any material, compound, mixture, or 40 preparation that contains any quantity of the following 41 hallucinogenic substances or that contains any of their salts, 42 isomers, including optical, positional, or geometric isomers, 43 homologues, nitrogen-heterocyclic analogs, esters, ethers, and 44 salts of isomers, homologues, nitrogen-heterocyclic analogs, 45 esters, or ethers, if the existence of such salts, isomers, and 46 salts of isomers is possible within the specific chemical 47 designation or class description: 48 1.Alpha-Ethyltryptamine. 49 2.4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2 50 oxazoline). 51 3.Aminorex (2-Amino-5-phenyl-2-oxazoline). 52 4.DOB (4-Bromo-2,5-dimethoxyamphetamine). 53 5.2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 54 6.Bufotenine. 55 7.Cannabis. 56 8.Cathinone. 57 9.DET (Diethyltryptamine). 58 10.2,5-Dimethoxyamphetamine. 59 11.DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 60 12.DMT (Dimethyltryptamine). 61 13.PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 62 analog of phencyclidine). 63 14.JB-318 (N-Ethyl-3-piperidyl benzilate). 64 15.N-Ethylamphetamine. 65 16.Fenethylline. 66 17.3,4-Methylenedioxy-N-hydroxyamphetamine. 67 18.Ibogaine. 68 19.LSD (Lysergic acid diethylamide). 69 20.Mescaline. 70 21.Methcathinone. 71 22.5-Methoxy-3,4-methylenedioxyamphetamine. 72 23.PMA (4-Methoxyamphetamine). 73 24.PMMA (4-Methoxymethamphetamine). 74 25.DOM (4-Methyl-2,5-dimethoxyamphetamine). 75 26.MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 76 27.MDA (3,4-Methylenedioxyamphetamine). 77 28.JB-336 (N-Methyl-3-piperidyl benzilate). 78 29.N,N-Dimethylamphetamine. 79 30.Parahexyl. 80 31.Peyote. 81 32.PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 82 analog of phencyclidine). 83 33.Psilocybin. 84 34.Psilocyn. 85 35.Salvia divinorum, except for any drug product approved 86 by the United States Food and Drug Administration which contains 87 Salvia divinorum or its isomers, esters, ethers, salts, and 88 salts of isomers, esters, and ethers, if the existence of such 89 isomers, esters, ethers, and salts is possible within the 90 specific chemical designation. 91 36.Salvinorin A, except for any drug product approved by 92 the United States Food and Drug Administration which contains 93 Salvinorin A or its isomers, esters, ethers, salts, and salts of 94 isomers, esters, and ethers, if the existence of such isomers, 95 esters, ethers, and salts is possible within the specific 96 chemical designation. 97 37.Xylazine, except for a xylazine animal drug product 98 approved by the United States Food and Drug Administration, the 99 use of which conforms to the approved application or is 100 authorized under 21 U.S.C. s. 360b(a)(4). The manufacture, 101 importation, distribution, prescribing, or sale of xylazine for 102 human use is not subject to this exception. 103 38.TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine) 104 (Thiophene analog of phencyclidine). 105 39.3,4,5-Trimethoxyamphetamine. 106 40.Methylone (3,4-Methylenedioxymethcathinone). 107 41.MDPV (3,4-Methylenedioxypyrovalerone). 108 42.Methylmethcathinone. 109 43.Methoxymethcathinone. 110 44.Fluoromethcathinone. 111 45.Methylethcathinone. 112 46.CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2 113 yl)phenol) and its dimethyloctyl (C8) homologue. 114 47.HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2 115 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol]. 116 48.JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 117 49.JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 118 50.JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1 119 naphthoyl)indole). 120 51.BZP (Benzylpiperazine). 121 52.Fluorophenylpiperazine. 122 53.Methylphenylpiperazine. 123 54.Chlorophenylpiperazine. 124 55.Methoxyphenylpiperazine. 125 56.DBZP (1,4-Dibenzylpiperazine). 126 57.TFMPP (Trifluoromethylphenylpiperazine). 127 58.MBDB (Methylbenzodioxolylbutanamine) or (3,4 128 Methylenedioxy-N-methylbutanamine). 129 59.5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 130 60.5-Hydroxy-N-methyltryptamine. 131 61.5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 132 62.5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 133 63.Methyltryptamine. 134 64.5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 135 65.5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 136 66.Tyramine (4-Hydroxyphenethylamine). 137 67.5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 138 68.DiPT (N,N-Diisopropyltryptamine). 139 69.DPT (N,N-Dipropyltryptamine). 140 70.4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 141 71.5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 142 72.DOI (4-Iodo-2,5-dimethoxyamphetamine). 143 73.DOC (4-Chloro-2,5-dimethoxyamphetamine). 144 74.2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 145 75.2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 146 76.2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 147 77.2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 148 78.2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 149 79.2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 150 80.2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 151 81.Butylone (3,4-Methylenedioxy-alpha 152 methylaminobutyrophenone). 153 82.Ethcathinone. 154 83.Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 155 84.Naphyrone (Naphthylpyrovalerone). 156 85.Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone). 157 86.3,4-Methylenedioxy-N,N-diethylcathinone. 158 87.3,4-Methylenedioxy-propiophenone. 159 88.3,4-Methylenedioxy-alpha-bromopropiophenone. 160 89.3,4-Methylenedioxy-propiophenone-2-oxime. 161 90.3,4-Methylenedioxy-N-acetylcathinone. 162 91.3,4-Methylenedioxy-N-acetylmethcathinone. 163 92.3,4-Methylenedioxy-N-acetylethcathinone. 164 93.Bromomethcathinone. 165 94.Buphedrone (alpha-Methylamino-butyrophenone). 166 95.Eutylone (3,4-Methylenedioxy-alpha 167 ethylaminobutyrophenone). 168 96.Dimethylcathinone. 169 97.Dimethylmethcathinone. 170 98.Pentylone (3,4-Methylenedioxy-alpha 171 methylaminovalerophenone). 172 99.MDPPP (3,4-Methylenedioxy-alpha 173 pyrrolidinopropiophenone). 174 100.MDPBP (3,4-Methylenedioxy-alpha 175 pyrrolidinobutyrophenone). 176 101.MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 177 102.MPHP (Methyl-alpha-pyrrolidinohexanophenone). 178 103.BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 179 (Benocyclidine). 180 104.F-MABP (Fluoromethylaminobutyrophenone). 181 105.MeO-PBP (Methoxypyrrolidinobutyrophenone). 182 106.Et-PBP (Ethylpyrrolidinobutyrophenone). 183 107.3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 184 108.Me-EABP (Methylethylaminobutyrophenone). 185 109.Etizolam. 186 110.PPP (Pyrrolidinopropiophenone). 187 111.PBP (Pyrrolidinobutyrophenone). 188 112.PVP (Pyrrolidinovalerophenone) or 189 (Pyrrolidinopentiophenone). 190 113.MPPP (Methyl-alpha-pyrrolidinopropiophenone). 191 114.JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 192 115.JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 193 116.JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 194 117.JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 195 118.JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 196 119.JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 197 120.JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 198 121.JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan 199 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 200 122.JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 201 123.JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 202 124.JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 203 125.JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 204 126.JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 205 127.JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 206 128.JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 207 129.JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole). 208 130.HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3 209 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1 210 ol). 211 131.HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan 212 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] 213 methanol). 214 132.HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1 215 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene 216 1,4-dione). 217 133.CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene). 218 134.CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy) 219 undecanamide). 220 135.CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy) 221 undecanamide). 222 136.CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2 223 methyloctan-2-yl)phenol). 224 137.AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 225 138.AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole). 226 139.RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 227 140.RCS-8 (1-(2-Cyclohexylethyl)-3-(2 228 methoxyphenylacetyl)indole). 229 141.WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4 230 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1 231 naphthalenylmethanone). 232 142.WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4 233 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1 234 naphthalenylmethanone). 235 143.Pentedrone (alpha-Methylaminovalerophenone). 236 144.Fluoroamphetamine. 237 145.Fluoromethamphetamine. 238 146.Methoxetamine. 239 147.Methiopropamine. 240 148.Methylbuphedrone (Methyl-alpha 241 methylaminobutyrophenone). 242 149.APB ((2-Aminopropyl)benzofuran). 243 150.APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran). 244 151.UR-144 (1-Pentyl-3-(2,2,3,3 245 tetramethylcyclopropanoyl)indole). 246 152.XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3 247 tetramethylcyclopropanoyl)indole). 248 153.Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3 249 tetramethylcyclopropanoyl)indole). 250 154.AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide). 251 155.AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2 252 iodobenzoyl)indole). 253 156.STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3 254 carboxamide). 255 157.URB-597 ((3-(Aminocarbonyl)[1,1-biphenyl]-3-yl) 256 cyclohexylcarbamate). 257 158.URB-602 ([1,1-Biphenyl]-3-yl-carbamic acid, 258 cyclohexyl ester). 259 159.URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1 260 benzoxazin-4-one). 261 160.2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 262 161.2C-H (2,5-Dimethoxyphenethylamine). 263 162.2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 264 163.2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 265 164.25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2 266 methoxybenzyl)]phenethylamine). 267 165.MDMA (3,4-Methylenedioxymethamphetamine). 268 166.PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 269 167.Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3 270 carboxylate). 271 168.BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3 272 carboxylate). 273 169.Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole 274 3-carboxamide). 275 170.AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 276 pentylindazole-3-carboxamide). 277 171.AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 278 (4-fluorobenzyl)indazole-3-carboxamide). 279 172.ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl) 280 1-pentylindazole-3-carboxamide). 281 173.Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2 282 yl)-1-(fluoropentyl)indole-3-carboxamide). 283 174.25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2 284 methoxybenzyl)]phenethylamine). 285 175.25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2 286 methoxybenzyl)]phenethylamine). 287 176.AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 288 (cyclohexylmethyl)indazole-3-carboxamide). 289 177.FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3 290 carboxylate). 291 178.Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole 292 3-carboxamide). 293 179.Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1 294 (fluoropentyl)indazole-3-carboxamide). 295 180.THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole). 296 181.AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl 297 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol). 298 182.AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9 299 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a 300 hexahydrobenzo[c]chromen-1-ol). 301 183.AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9 302 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a 303 hexahydrobenzo[c]chromen-1-ol). 304 184.AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl) 305 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 306 diol). 307 185.HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6 308 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a 309 tetrahydro-6aH-benzo[c]chromen-1-ol). 310 186.HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl 311 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione). 312 187.MAPB ((2-Methylaminopropyl)benzofuran). 313 188.5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine). 314 189.6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine). 315 190.Synthetic Cannabinoids.Unless specifically excepted 316 or unless listed in another schedule or contained within a 317 pharmaceutical product approved by the United States Food and 318 Drug Administration, any material, compound, mixture, or 319 preparation that contains any quantity of a synthetic 320 cannabinoid found to be in any of the following chemical class 321 descriptions, or homologues, nitrogen-heterocyclic analogs, 322 isomers (including optical, positional, or geometric), esters, 323 ethers, salts, and salts of homologues, nitrogen-heterocyclic 324 analogs, isomers, esters, or ethers, whenever the existence of 325 such homologues, nitrogen-heterocyclic analogs, isomers, esters, 326 ethers, salts, and salts of isomers, esters, or ethers is 327 possible within the specific chemical class or designation. 328 Since nomenclature of these synthetically produced cannabinoids 329 is not internationally standardized and may continually evolve, 330 these structures or the compounds of these structures shall be 331 included under this subparagraph, regardless of their specific 332 numerical designation of atomic positions covered, if it can be 333 determined through a recognized method of scientific testing or 334 analysis that the substance contains properties that fit within 335 one or more of the following categories: 336 a.Tetrahydrocannabinols.Any tetrahydrocannabinols 337 naturally contained in a plant of the genus Cannabis, the 338 synthetic equivalents of the substances contained in the plant 339 or in the resinous extracts of the genus Cannabis, or synthetic 340 substances, derivatives, and their isomers with similar chemical 341 structure and pharmacological activity, including, but not 342 limited to, Delta 9 tetrahydrocannabinols and their optical 343 isomers, Delta 8 tetrahydrocannabinols and their optical 344 isomers, Delta 6a,10a tetrahydrocannabinols and their optical 345 isomers, or any compound containing a tetrahydrobenzo[c]chromene 346 structure with substitution at either or both the 3-position or 347 9-position, with or without substitution at the 1-position with 348 hydroxyl or alkoxy groups, including, but not limited to: 349 (I)Tetrahydrocannabinol. 350 (II)HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3 351 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1 352 ol). 353 (III)HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3 354 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1 355 ol). 356 (IV)JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3 357 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 358 (V)JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan 359 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 360 (VI)JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan 361 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 362 (VII)JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3 363 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 364 (VIII)AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl) 365 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol). 366 (IX)AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl 367 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol). 368 (X)Parahexyl. 369 b.Naphthoylindoles, Naphthoylindazoles, 370 Naphthoylcarbazoles, Naphthylmethylindoles, 371 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.Any 372 compound containing a naphthoylindole, naphthoylindazole, 373 naphthoylcarbazole, naphthylmethylindole, 374 naphthylmethylindazole, or naphthylmethylcarbazole structure, 375 with or without substitution on the indole, indazole, or 376 carbazole ring to any extent, whether or not substituted on the 377 naphthyl ring to any extent, including, but not limited to: 378 (I)JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 379 (II)JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1 380 naphthoyl)indole). 381 (III)JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 382 (IV)JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole). 383 (V)JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 384 (VI)JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 385 (VII)JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 386 (VIII)JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole). 387 (IX)JWH-071 (1-Ethyl-3-(1-naphthoyl)indole). 388 (X)JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 389 (XI)JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 390 (XII)JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole). 391 (XIII)JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 392 (XIV)JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1 393 naphthoyl)indole). 394 (XV)JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole). 395 (XVI)JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 396 (XVII)JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1 397 naphthoyl)indole). 398 (XVIII)JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole). 399 (XIX)JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 400 (XX)JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole). 401 (XXI)JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole). 402 (XXII)JWH-184 (1-Pentyl-3-[(4-methyl)-1 403 naphthylmethyl]indole). 404 (XXIII)JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1 405 naphthoyl)indole). 406 (XXIV)JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1 407 naphthoyl)indole). 408 (XXV)JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1 409 naphthoyl)indole). 410 (XXVI)JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 411 (XXVII)JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole). 412 (XXVIII)JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole). 413 (XXIX)JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole). 414 (XXX)JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole). 415 (XXXI)AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1 416 naphthoyl)indole). 417 (XXXII)AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1 418 naphthoyl)indole). 419 (XXXIII)AM-2201 (1-(5-Fluoropentyl)-3-(1 420 naphthoyl)indole). 421 (XXXIV)Chloro JWH-018 (1-(Chloropentyl)-3-(1 422 naphthoyl)indole). 423 (XXXV)Bromo JWH-018 (1-(Bromopentyl)-3-(1 424 naphthoyl)indole). 425 (XXXVI)AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole). 426 (XXXVII)THJ-2201 (1-(5-Fluoropentyl)-3-(1 427 naphthoyl)indazole). 428 (XXXVIII)MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1 429 naphthoyl)indole). 430 (XXXIX)EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1 431 naphthoyl)indole). 432 (XL)EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole). 433 (XLI)EG-2201 (9-(5-Fluoropentyl)-3-(1 434 naphthoyl)carbazole). 435 c.Naphthoylpyrroles.Any compound containing a 436 naphthoylpyrrole structure, with or without substitution on the 437 pyrrole ring to any extent, whether or not substituted on the 438 naphthyl ring to any extent, including, but not limited to: 439 (I)JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole). 440 (II)JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole). 441 (III)JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole). 442 (IV)JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole). 443 (V)JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole). 444 (VI)JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1 445 naphthoyl)pyrrole). 446 (VII)JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1 447 naphthoyl)pyrrole). 448 (VIII)JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1 449 naphthoyl)pyrrole). 450 (IX)JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1 451 naphthoyl)pyrrole). 452 (X)JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1 453 naphthoyl)pyrrole). 454 d.Naphthylmethylenindenes.Any compound containing a 455 naphthylmethylenindene structure, with or without substitution 456 at the 3-position of the indene ring to any extent, whether or 457 not substituted on the naphthyl ring to any extent, including, 458 but not limited to, JWH-176 (3-Pentyl-1 459 (naphthylmethylene)indene). 460 e.Phenylacetylindoles and Phenylacetylindazoles.Any 461 compound containing a phenylacetylindole or phenylacetylindazole 462 structure, with or without substitution on the indole or 463 indazole ring to any extent, whether or not substituted on the 464 phenyl ring to any extent, including, but not limited to: 465 (I)JWH-167 (1-Pentyl-3-(phenylacetyl)indole). 466 (II)JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 467 (III)JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 468 (IV)JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 469 (V)JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 470 (VI)JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 471 (VII)Cannabipiperidiethanone. 472 (VIII)RCS-8 (1-(2-Cyclohexylethyl)-3-(2 473 methoxyphenylacetyl)indole). 474 f.Cyclohexylphenols.Any compound containing a 475 cyclohexylphenol structure, with or without substitution at the 476 5-position of the phenolic ring to any extent, whether or not 477 substituted on the cyclohexyl ring to any extent, including, but 478 not limited to: 479 (I)CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2 480 yl)phenol). 481 (II)Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8) 482 homologue). 483 (III)CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2 484 methyloctan-2-yl)phenol). 485 g.Benzoylindoles and Benzoylindazoles.Any compound 486 containing a benzoylindole or benzoylindazole structure, with or 487 without substitution on the indole or indazole ring to any 488 extent, whether or not substituted on the phenyl ring to any 489 extent, including, but not limited to: 490 (I)AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole). 491 (II)AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 492 (III)AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2 493 iodo-5-nitrobenzoyl)indole). 494 (IV)Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4 495 methoxybenzoyl)indole). 496 (V)AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2 497 iodobenzoyl)indole). 498 (VI)RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 499 (VII)RCS-4 C4 homologue (1-Butyl-3-(4 500 methoxybenzoyl)indole). 501 (VIII)AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo 502 3-(4-methoxybenzoyl)indole). 503 h.Tetramethylcyclopropanoylindoles and 504 Tetramethylcyclopropanoylindazoles.Any compound containing a 505 tetramethylcyclopropanoylindole or 506 tetramethylcyclopropanoylindazole structure, with or without 507 substitution on the indole or indazole ring to any extent, 508 whether or not substituted on the tetramethylcyclopropyl group 509 to any extent, including, but not limited to: 510 (I)UR-144 (1-Pentyl-3-(2,2,3,3 511 tetramethylcyclopropanoyl)indole). 512 (II)XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3 513 tetramethylcyclopropanoyl)indole). 514 (III)Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3 515 tetramethylcyclopropanoyl)indole). 516 (IV)A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3 517 tetramethylcyclopropanoyl)indole). 518 (V)A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3 519 tetramethylcyclopropanoyl)indole). 520 (VI)M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3 521 tetramethylcyclopropanoyl)indole). 522 (VII)FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3 523 tetramethylcyclopropanoyl)indole). 524 (VIII)FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3 525 tetramethylcyclopropanoyl)indazole). 526 (IX)XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3 527 tetramethylcyclopropanoyl)indole). 528 (X)AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3 529 tetramethylcyclopropanoyl)indole). 530 i.Adamantoylindoles, Adamantoylindazoles, Adamantylindole 531 carboxamides, and Adamantylindazole carboxamides.Any compound 532 containing an adamantoyl indole, adamantoyl indazole, adamantyl 533 indole carboxamide, or adamantyl indazole carboxamide structure, 534 with or without substitution on the indole or indazole ring to 535 any extent, whether or not substituted on the adamantyl ring to 536 any extent, including, but not limited to: 537 (I)AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide). 538 (II)Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole 539 3-carboxamide). 540 (III)STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3 541 carboxamide). 542 (IV)AM-1248 (1-(1-Methylpiperidine)methyl-3-(1 543 adamantoyl)indole). 544 (V)AB-001 (1-Pentyl-3-(1-adamantoyl)indole). 545 (VI)APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide). 546 (VII)Fluoro AB-001 (1-(Fluoropentyl)-3-(1 547 adamantoyl)indole). 548 j.Quinolinylindolecarboxylates, 549 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, 550 and Quinolinylindazolecarboxamides.Any compound containing a 551 quinolinylindole carboxylate, quinolinylindazole carboxylate, 552 isoquinolinylindole carboxylate, isoquinolinylindazole 553 carboxylate, quinolinylindole carboxamide, quinolinylindazole 554 carboxamide, isoquinolinylindole carboxamide, or 555 isoquinolinylindazole carboxamide structure, with or without 556 substitution on the indole or indazole ring to any extent, 557 whether or not substituted on the quinoline or isoquinoline ring 558 to any extent, including, but not limited to: 559 (I)PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 560 (II)Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3 561 carboxylate). 562 (III)BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3 563 carboxylate). 564 (IV)FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3 565 carboxylate). 566 (V)NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate). 567 (VI)Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole 568 3-carboxylate). 569 (VII)FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole 570 3-carboxylate). 571 (VIII)THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide). 572 (IX)Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3 573 carboxamide). 574 k.Naphthylindolecarboxylates and 575 Naphthylindazolecarboxylates.Any compound containing a 576 naphthylindole carboxylate or naphthylindazole carboxylate 577 structure, with or without substitution on the indole or 578 indazole ring to any extent, whether or not substituted on the 579 naphthyl ring to any extent, including, but not limited to: 580 (I)NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3 581 carboxylate). 582 (II)SDB-005 (1-Naphthalenyl 1-pentylindazole-3 583 carboxylate). 584 (III)Fluoro SDB-005 (1-Naphthalenyl 1 585 (fluoropentyl)indazole-3-carboxylate). 586 (IV)FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3 587 carboxylate). 588 (V)3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3 589 carboxylate). 590 l.Naphthylindole carboxamides and Naphthylindazole 591 carboxamides.Any compound containing a naphthylindole 592 carboxamide or naphthylindazole carboxamide structure, with or 593 without substitution on the indole or indazole ring to any 594 extent, whether or not substituted on the naphthyl ring to any 595 extent, including, but not limited to: 596 (I)NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide). 597 (II)Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole 598 3-carboxamide). 599 (III)Chloro-NNEI (N-Naphthalen-1-yl 1 600 (chloropentyl)indole-3-carboxamide). 601 (IV)MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3 602 carboxamide). 603 (V)Fluoro MN-18 (N-Naphthalen-1-yl 1 604 (fluoropentyl)indazole-3-carboxamide). 605 m.Alkylcarbonyl indole carboxamides, Alkylcarbonyl 606 indazole carboxamides, Alkylcarbonyl indole carboxylates, and 607 Alkylcarbonyl indazole carboxylates.Any compound containing an 608 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl, 609 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3 610 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an 611 indole carboxamide, indazole carboxamide, indole carboxylate, or 612 indazole carboxylate, with or without substitution on the indole 613 or indazole ring to any extent, whether or not substituted on 614 the alkylcarbonyl group to any extent, including, but not 615 limited to: 616 (I)ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1 617 pentylindole-3-carboxamide). 618 (II)Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2 619 yl)-1-(fluoropentyl)indole-3-carboxamide). 620 (III)Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 621 (fluoropentyl)indole-3-carboxamide). 622 (IV)AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 623 pentylindazole-3-carboxamide). 624 (V)Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl) 625 1-(fluoropentyl)indazole-3-carboxamide). 626 (VI)ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl) 627 1-pentylindazole-3-carboxamide). 628 (VII)Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1 629 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide). 630 (VIII)AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 631 (4-fluorobenzyl)indazole-3-carboxamide). 632 (IX)ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2 633 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide). 634 (X)AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1 635 (cyclohexylmethyl)indazole-3-carboxamide). 636 (XI)MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1 637 (cyclohexylmethyl)indazole-3-carboxamide). 638 (XII)MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2 639 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide). 640 (XIII)AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1 641 pentylindazole-3-carboxamide). 642 (XIV)Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1 643 (fluoropentyl)indazole-3-carboxamide). 644 (XV)FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4 645 fluorobenzyl)indazole-3-carboxamide). 646 (XVI)MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan 647 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide). 648 (XVII)MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan 649 2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide). 650 (XVIII)MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan 651 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide). 652 (XIX)PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5 653 fluoropentyl)indole-3-carboxamide). 654 (XX)PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5 655 fluoropentyl)indazole-3-carboxamide). 656 (XXI)PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1 657 (cyclohexylmethyl)indazole-3-carboxamide). 658 (XXII)PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4 659 fluorobenzyl)indazole-3-carboxamide). 660 (XXIII)MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan 661 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate). 662 n.Cumylindolecarboxamides and Cumylindazolecarboxamides. 663 Any compound containing a N-(2-phenylpropan-2-yl) indole 664 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide 665 structure, with or without substitution on the indole or 666 indazole ring to any extent, whether or not substituted on the 667 phenyl ring of the cumyl group to any extent, including, but not 668 limited to: 669 (I)CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3 670 carboxamide). 671 (II)Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1 672 (fluoropentyl)indole-3-carboxamide). 673 o.Other Synthetic Cannabinoids.Any material, compound, 674 mixture, or preparation that contains any quantity of a 675 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.: 676 (I)With or without modification or replacement of a 677 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage 678 between either two core rings, or linkage between a core ring 679 and group structure, with or without the addition of a carbon or 680 replacement of a carbon; 681 (II)With or without replacement of a core ring or group 682 structure, whether or not substituted on the ring or group 683 structures to any extent; and 684 (III)Is a cannabinoid receptor agonist, unless 685 specifically excepted or unless listed in another schedule or 686 contained within a pharmaceutical product approved by the United 687 States Food and Drug Administration. 688 191.Substituted Cathinones.Unless specifically excepted, 689 listed in another schedule, or contained within a pharmaceutical 690 product approved by the United States Food and Drug 691 Administration, any material, compound, mixture, or preparation, 692 including its salts, isomers, esters, or ethers, and salts of 693 isomers, esters, or ethers, whenever the existence of such salts 694 is possible within any of the following specific chemical 695 designations: 696 a.Any compound containing a 2-amino-1-phenyl-1-propanone 697 structure; 698 b.Any compound containing a 2-amino-1-naphthyl-1-propanone 699 structure; or 700 c.Any compound containing a 2-amino-1-thiophenyl-1 701 propanone structure, 702 703 whether or not the compound is further modified: 704 (I)With or without substitution on the ring system to any 705 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy, 706 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused 707 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide 708 substituents; 709 (II)With or without substitution at the 3-propanone 710 position with an alkyl substituent or removal of the methyl 711 group at the 3-propanone position; 712 (III)With or without substitution at the 2-amino nitrogen 713 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or 714 not further substituted in the ring system; or 715 (IV)With or without inclusion of the 2-amino nitrogen atom 716 in a cyclic structure, including, but not limited to: 717 (A)Methcathinone. 718 (B)Ethcathinone. 719 (C)Methylone (3,4-Methylenedioxymethcathinone). 720 (D)2,3-Methylenedioxymethcathinone. 721 (E)MDPV (3,4-Methylenedioxypyrovalerone). 722 (F)Methylmethcathinone. 723 (G)Methoxymethcathinone. 724 (H)Fluoromethcathinone. 725 (I)Methylethcathinone. 726 (J)Butylone (3,4-Methylenedioxy-alpha 727 methylaminobutyrophenone). 728 (K)Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 729 (L)BMDP (3,4-Methylenedioxy-N-benzylcathinone). 730 (M)Naphyrone (Naphthylpyrovalerone). 731 (N)Bromomethcathinone. 732 (O)Buphedrone (alpha-Methylaminobutyrophenone). 733 (P)Eutylone (3,4-Methylenedioxy-alpha 734 ethylaminobutyrophenone). 735 (Q)Dimethylcathinone. 736 (R)Dimethylmethcathinone. 737 (S)Pentylone (3,4-Methylenedioxy-alpha 738 methylaminovalerophenone). 739 (T)Pentedrone (alpha-Methylaminovalerophenone). 740 (U)MDPPP (3,4-Methylenedioxy-alpha 741 pyrrolidinopropiophenone). 742 (V)MDPBP (3,4-Methylenedioxy-alpha 743 pyrrolidinobutyrophenone). 744 (W)MPPP (Methyl-alpha-pyrrolidinopropiophenone). 745 (X)PPP (Pyrrolidinopropiophenone). 746 (Y)PVP (Pyrrolidinovalerophenone) or 747 (Pyrrolidinopentiophenone). 748 (Z)MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 749 (AA)MPHP (Methyl-alpha-pyrrolidinohexanophenone). 750 (BB)F-MABP (Fluoromethylaminobutyrophenone). 751 (CC)Me-EABP (Methylethylaminobutyrophenone). 752 (DD)PBP (Pyrrolidinobutyrophenone). 753 (EE)MeO-PBP (Methoxypyrrolidinobutyrophenone). 754 (FF)Et-PBP (Ethylpyrrolidinobutyrophenone). 755 (GG)3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 756 (HH)Dimethylone (3,4-Methylenedioxy-N,N 757 dimethylcathinone). 758 (II)3,4-Methylenedioxy-N,N-diethylcathinone. 759 (JJ)3,4-Methylenedioxy-N-acetylcathinone. 760 (KK)3,4-Methylenedioxy-N-acetylmethcathinone. 761 (LL)3,4-Methylenedioxy-N-acetylethcathinone. 762 (MM)Methylbuphedrone (Methyl-alpha 763 methylaminobutyrophenone). 764 (NN)Methyl-alpha-methylaminohexanophenone. 765 (OO)N-Ethyl-N-methylcathinone. 766 (PP)PHP (Pyrrolidinohexanophenone). 767 (QQ)PV8 (Pyrrolidinoheptanophenone). 768 (RR)Chloromethcathinone. 769 (SS)4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone. 770 192.Substituted Phenethylamines.Unless specifically 771 excepted or unless listed in another schedule, or contained 772 within a pharmaceutical product approved by the United States 773 Food and Drug Administration, any material, compound, mixture, 774 or preparation, including its salts, isomers, esters, or ethers, 775 and salts of isomers, esters, or ethers, whenever the existence 776 of such salts is possible within any of the following specific 777 chemical designations, any compound containing a phenethylamine 778 structure, without a beta-keto group, and without a benzyl group 779 attached to the amine group, whether or not the compound is 780 further modified with or without substitution on the phenyl ring 781 to any extent with alkyl, alkylthio, nitro, alkoxy, thio, 782 halide, fused alkylenedioxy, fused furan, fused benzofuran, 783 fused dihydrofuran, or fused tetrahydropyran substituents, 784 whether or not further substituted on a ring to any extent, with 785 or without substitution at the alpha or beta position by any 786 alkyl substituent, with or without substitution at the nitrogen 787 atom, and with or without inclusion of the 2-amino nitrogen atom 788 in a cyclic structure, including, but not limited to: 789 a.2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 790 b.2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 791 c.2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 792 d.2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 793 e.2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 794 f.2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 795 g.2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 796 h.2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 797 i.2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 798 j.2C-H (2,5-Dimethoxyphenethylamine). 799 k.2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 800 l.2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 801 m.MDMA (3,4-Methylenedioxymethamphetamine). 802 n.MBDB (Methylbenzodioxolylbutanamine) or (3,4 803 Methylenedioxy-N-methylbutanamine). 804 o.MDA (3,4-Methylenedioxyamphetamine). 805 p.2,5-Dimethoxyamphetamine. 806 q.Fluoroamphetamine. 807 r.Fluoromethamphetamine. 808 s.MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 809 t.DOB (4-Bromo-2,5-dimethoxyamphetamine). 810 u.DOC (4-Chloro-2,5-dimethoxyamphetamine). 811 v.DOET (4-Ethyl-2,5-dimethoxyamphetamine). 812 w.DOI (4-Iodo-2,5-dimethoxyamphetamine). 813 x.DOM (4-Methyl-2,5-dimethoxyamphetamine). 814 y.PMA (4-Methoxyamphetamine). 815 z.N-Ethylamphetamine. 816 aa.3,4-Methylenedioxy-N-hydroxyamphetamine. 817 bb.5-Methoxy-3,4-methylenedioxyamphetamine. 818 cc.PMMA (4-Methoxymethamphetamine). 819 dd.N,N-Dimethylamphetamine. 820 ee.3,4,5-Trimethoxyamphetamine. 821 ff.4-APB (4-(2-Aminopropyl)benzofuran). 822 gg.5-APB (5-(2-Aminopropyl)benzofuran). 823 hh.6-APB (6-(2-Aminopropyl)benzofuran). 824 ii.7-APB (7-(2-Aminopropyl)benzofuran). 825 jj.4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran). 826 kk.5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran). 827 ll.6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran). 828 mm.7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran). 829 nn.4-MAPB (4-(2-Methylaminopropyl)benzofuran). 830 oo.5-MAPB (5-(2-Methylaminopropyl)benzofuran). 831 pp.6-MAPB (6-(2-Methylaminopropyl)benzofuran). 832 qq.7-MAPB (7-(2-Methylaminopropyl)benzofuran). 833 rr.5-EAPB (5-(2-Ethylaminopropyl)benzofuran). 834 ss.5-MAPDB (5-(2-Methylaminopropyl)-2,3 835 dihydrobenzofuran), 836 837 which does not include phenethylamine, mescaline as described in 838 subparagraph 20., substituted cathinones as described in 839 subparagraph 191., N-Benzyl phenethylamine compounds as 840 described in subparagraph 193., or methamphetamine as described 841 in subparagraph (2)(c)5. 842 193.N-Benzyl Phenethylamine Compounds.Unless specifically 843 excepted or unless listed in another schedule, or contained 844 within a pharmaceutical product approved by the United States 845 Food and Drug Administration, any material, compound, mixture, 846 or preparation, including its salts, isomers, esters, or ethers, 847 and salts of isomers, esters, or ethers, whenever the existence 848 of such salts is possible within any of the following specific 849 chemical designations, any compound containing a phenethylamine 850 structure without a beta-keto group, with substitution on the 851 nitrogen atom of the amino group with a benzyl substituent, with 852 or without substitution on the phenyl or benzyl ring to any 853 extent with alkyl, alkoxy, thio, alkylthio, halide, fused 854 alkylenedioxy, fused furan, fused benzofuran, or fused 855 tetrahydropyran substituents, whether or not further substituted 856 on a ring to any extent, with or without substitution at the 857 alpha position by any alkyl substituent, including, but not 858 limited to: 859 a.25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2 860 methoxybenzyl)]phenethylamine). 861 b.25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2 862 hydroxybenzyl)]phenethylamine). 863 c.25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2 864 fluorobenzyl)]phenethylamine). 865 d.25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3 866 methylenedioxybenzyl)]phenethylamine). 867 e.25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2 868 methoxybenzyl)]phenethylamine). 869 f.25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2 870 hydroxybenzyl)]phenethylamine). 871 g.25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2 872 fluorobenzyl)]phenethylamine). 873 h.25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3 874 methylenedioxybenzyl)]phenethylamine). 875 i.25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2 876 methoxybenzyl)]phenethylamine). 877 j.25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2 878 methoxybenzyl)]phenethylamine). 879 k.25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2 880 methoxybenzyl)]phenethylamine). 881 l.25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2 882 methoxybenzyl)]phenethylamine). 883 m.25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2 884 hydroxybenzyl)]phenethylamine). 885 n.25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2 886 fluorobenzyl)]phenethylamine). 887 o.25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3 888 methylenedioxybenzyl)]phenethylamine). 889 p.25H-NBOMe (2,5-Dimethoxy-[N-(2 890 methoxybenzyl)]phenethylamine). 891 q.25H-NBOH (2,5-Dimethoxy-[N-(2 892 hydroxybenzyl)]phenethylamine). 893 r.25H-NBF (2,5-Dimethoxy-[N-(2 894 fluorobenzyl)]phenethylamine). 895 s.25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2 896 methoxybenzyl)]phenethylamine), 897 898 which does not include substituted cathinones as described in 899 subparagraph 191. 900 194.Substituted Tryptamines.Unless specifically excepted 901 or unless listed in another schedule, or contained within a 902 pharmaceutical product approved by the United States Food and 903 Drug Administration, any material, compound, mixture, or 904 preparation containing a 2-(1H-indol-3-yl)ethanamine, for 905 example tryptamine, structure with or without mono- or di 906 substitution of the amine nitrogen with alkyl or alkenyl groups, 907 or by inclusion of the amino nitrogen atom in a cyclic 908 structure, whether or not substituted at the alpha position with 909 an alkyl group, whether or not substituted on the indole ring to 910 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy 911 groups, including, but not limited to: 912 a.Alpha-Ethyltryptamine. 913 b.Bufotenine. 914 c.DET (Diethyltryptamine). 915 d.DMT (Dimethyltryptamine). 916 e.MET (N-Methyl-N-ethyltryptamine). 917 f.DALT (N,N-Diallyltryptamine). 918 g.EiPT (N-Ethyl-N-isopropyltryptamine). 919 h.MiPT (N-Methyl-N-isopropyltryptamine). 920 i.5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 921 j.5-Hydroxy-N-methyltryptamine. 922 k.5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 923 l.5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 924 m.Methyltryptamine. 925 n.5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 926 o.5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 927 p.5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 928 q.DiPT (N,N-Diisopropyltryptamine). 929 r.DPT (N,N-Dipropyltryptamine). 930 s.4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 931 t.5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 932 u.4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine). 933 v.4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine). 934 w.4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine). 935 x.4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine). 936 y.4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N 937 isopropyltryptamine). 938 z.Methyl-alpha-ethyltryptamine. 939 aa.Bromo-DALT (Bromo-N,N-diallyltryptamine), 940 941 which does not include tryptamine, psilocyn as described in 942 subparagraph 34., or psilocybin as described in subparagraph 33. 943 195.Substituted Phenylcyclohexylamines.Unless 944 specifically excepted or unless listed in another schedule, or 945 contained within a pharmaceutical product approved by the United 946 States Food and Drug Administration, any material, compound, 947 mixture, or preparation containing a phenylcyclohexylamine 948 structure, with or without any substitution on the phenyl ring, 949 any substitution on the cyclohexyl ring, any replacement of the 950 phenyl ring with a thiophenyl or benzothiophenyl ring, with or 951 without substitution on the amine with alkyl, dialkyl, or alkoxy 952 substituents, inclusion of the nitrogen in a cyclic structure, 953 or any combination of the above, including, but not limited to: 954 a.BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 955 (Benocyclidine). 956 b.PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog 957 of phencyclidine). 958 c.PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine 959 analog of phencyclidine). 960 d.PCPr (Phenylcyclohexylpropylamine). 961 e.TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene 962 analog of phencyclidine). 963 f.PCEEA (Phenylcyclohexyl(ethoxyethylamine)). 964 g.PCMPA (Phenylcyclohexyl(methoxypropylamine)). 965 h.Methoxetamine. 966 i.3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine). 967 j.Bromo-PCP ((Bromophenyl)cyclohexylpiperidine). 968 k.Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine). 969 l.Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine). 970 m.Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine). 971 n.Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine). 972 o.Methyl-PCP ((Methylphenyl)cyclohexylpiperidine). 973 p.Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine). 974 q.Oxo-PCP ((Oxophenyl)cyclohexylpiperidine). 975 r.Amino-PCP ((Aminophenyl)cyclohexylpiperidine). 976 196.W-15, 4-chloro-N-[1-(2-phenylethyl)-2 977 piperidinylidene]-benzenesulfonamide. 978 197.W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2 979 piperidinylidene]-benzenesulfonamide. 980 198.AH-7921, 3,4-dichloro-N-[[1 981 (dimethylamino)cyclohexyl]methyl]-benzamide. 982 199.U47700, trans-3,4-dichloro-N-[2 983 (dimethylamino)cyclohexyl]-N-methyl-benzamide. 984 200.MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine, 985 dihydrochloride. 986 Section 2.Paragraph (i) of subsection (1) of section 987 893.13, Florida Statutes, is amended to read: 988 893.13Prohibited acts; penalties. 989 (1) 990 (i)Except as authorized by this chapter, a person commits 991 a felony of the first degree, punishable as provided in s. 992 775.082, s. 775.083, or s. 775.084, and must be sentenced to a 993 mandatory minimum term of imprisonment of 3 years, if: 994 1.The person sells, manufactures, or delivers, or 995 possesses with intent to sell, manufacture, or deliver, any of 996 the following: 997 a.Alfentanil, as described in s. 893.03(2)(b)1.; 998 b.Carfentanil, as described in s. 893.03(2)(b)6.; 999 c.Fentanyl, as described in s. 893.03(2)(b)9.; 1000 d.Sufentanil, as described in s. 893.03(2)(b)30.; 1001 e.A fentanyl derivative, as described in s. 1002 893.03(1)(a)63.; 1003 f.Xylazine, as described in s. 893.03(1)(c)37.; 1004 g.A controlled substance analog, as described in s. 1005 893.0356, of any substance described in sub-subparagraphs a.-f. 1006 sub-subparagraphs a.-e.; or 1007 h.g.A mixture containing any substance described in sub 1008 subparagraphs a.-g. sub-subparagraphs a.-f.; and 1009 2.The substance or mixture listed in subparagraph 1. is in 1010 a form that resembles, or is mixed, granulated, absorbed, spray 1011 dried, or aerosolized as or onto, coated on, in whole or in 1012 part, or solubilized with or into, a product, when such product 1013 or its packaging further has at least one of the following 1014 attributes: 1015 a.Resembles the trade dress of a branded food product, 1016 consumer food product, or logo food product; 1017 b.Incorporates an actual or fake registered copyright, 1018 service mark, or trademark; 1019 c.Resembles candy, cereal, a gummy, a vitamin, or a 1020 chewable product, such as a gum or gelatin-based product; or 1021 d.Contains a cartoon character imprint. 1022 Section 3.Paragraph (c) of subsection (1) of section 1023 893.135, Florida Statutes, is amended to read: 1024 893.135Trafficking; mandatory sentences; suspension or 1025 reduction of sentences; conspiracy to engage in trafficking. 1026 (1)Except as authorized in this chapter or in chapter 499 1027 and notwithstanding the provisions of s. 893.13: 1028 (c)1.A person who knowingly sells, purchases, 1029 manufactures, delivers, or brings into this state, or who is 1030 knowingly in actual or constructive possession of, 4 grams or 1031 more of any morphine, opium, hydromorphone, or any salt, 1032 derivative, isomer, or salt of an isomer thereof, including 1033 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or 1034 (3)(c)4., or 4 grams or more of any mixture containing any such 1035 substance, but less than 30 kilograms of such substance or 1036 mixture, commits a felony of the first degree, which felony 1037 shall be known as trafficking in illegal drugs, punishable as 1038 provided in s. 775.082, s. 775.083, or s. 775.084. If the 1039 quantity involved: 1040 a.Is 4 grams or more, but less than 14 grams, such person 1041 shall be sentenced to a mandatory minimum term of imprisonment 1042 of 3 years and shall be ordered to pay a fine of $50,000. 1043 b.Is 14 grams or more, but less than 28 grams, such person 1044 shall be sentenced to a mandatory minimum term of imprisonment 1045 of 15 years and shall be ordered to pay a fine of $100,000. 1046 c.Is 28 grams or more, but less than 30 kilograms, such 1047 person shall be sentenced to a mandatory minimum term of 1048 imprisonment of 25 years and shall be ordered to pay a fine of 1049 $500,000. 1050 2.A person who knowingly sells, purchases, manufactures, 1051 delivers, or brings into this state, or who is knowingly in 1052 actual or constructive possession of, 28 grams or more of 1053 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as 1054 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28 1055 grams or more of any mixture containing any such substance, 1056 commits a felony of the first degree, which felony shall be 1057 known as trafficking in hydrocodone, punishable as provided in 1058 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved: 1059 a.Is 28 grams or more, but less than 50 grams, such person 1060 shall be sentenced to a mandatory minimum term of imprisonment 1061 of 3 years and shall be ordered to pay a fine of $50,000. 1062 b.Is 50 grams or more, but less than 100 grams, such 1063 person shall be sentenced to a mandatory minimum term of 1064 imprisonment of 7 years and shall be ordered to pay a fine of 1065 $100,000. 1066 c.Is 100 grams or more, but less than 300 grams, such 1067 person shall be sentenced to a mandatory minimum term of 1068 imprisonment of 15 years and shall be ordered to pay a fine of 1069 $500,000. 1070 d.Is 300 grams or more, but less than 30 kilograms, such 1071 person shall be sentenced to a mandatory minimum term of 1072 imprisonment of 25 years and shall be ordered to pay a fine of 1073 $750,000. 1074 3.A person who knowingly sells, purchases, manufactures, 1075 delivers, or brings into this state, or who is knowingly in 1076 actual or constructive possession of, 7 grams or more of 1077 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt 1078 thereof, or 7 grams or more of any mixture containing any such 1079 substance, commits a felony of the first degree, which felony 1080 shall be known as trafficking in oxycodone, punishable as 1081 provided in s. 775.082, s. 775.083, or s. 775.084. If the 1082 quantity involved: 1083 a.Is 7 grams or more, but less than 14 grams, such person 1084 shall be sentenced to a mandatory minimum term of imprisonment 1085 of 3 years and shall be ordered to pay a fine of $50,000. 1086 b.Is 14 grams or more, but less than 25 grams, such person 1087 shall be sentenced to a mandatory minimum term of imprisonment 1088 of 7 years and shall be ordered to pay a fine of $100,000. 1089 c.Is 25 grams or more, but less than 100 grams, such 1090 person shall be sentenced to a mandatory minimum term of 1091 imprisonment of 15 years and shall be ordered to pay a fine of 1092 $500,000. 1093 d.Is 100 grams or more, but less than 30 kilograms, such 1094 person shall be sentenced to a mandatory minimum term of 1095 imprisonment of 25 years and shall be ordered to pay a fine of 1096 $750,000. 1097 4.a.A person who knowingly sells, purchases, manufactures, 1098 delivers, or brings into this state, or who is knowingly in 1099 actual or constructive possession of, 4 grams or more of: 1100 (I)Alfentanil, as described in s. 893.03(2)(b)1.; 1101 (II)Carfentanil, as described in s. 893.03(2)(b)6.; 1102 (III)Fentanyl, as described in s. 893.03(2)(b)9.; 1103 (IV)Sufentanil, as described in s. 893.03(2)(b)30.; 1104 (V)A fentanyl derivative, as described in s. 1105 893.03(1)(a)63.; 1106 (VI)A controlled substance analog, as described in s. 1107 893.0356, of any substance described in sub-sub-subparagraphs 1108 (I)-(V); or 1109 (VII)A mixture containing any substance described in sub 1110 sub-subparagraphs (I)-(VI), 1111 1112 commits a felony of the first degree, which felony shall be 1113 known as trafficking in dangerous fentanyl or fentanyl 1114 analogues, punishable as provided in s. 775.082, s. 775.083, or 1115 s. 775.084. 1116 b.If the quantity involved under sub-subparagraph a.: 1117 (I)Is 4 grams or more, but less than 14 grams, such person 1118 shall be sentenced to a mandatory minimum term of imprisonment 1119 of 7 years, and shall be ordered to pay a fine of $50,000. 1120 (II)Is 14 grams or more, but less than 28 grams, such 1121 person shall be sentenced to a mandatory minimum term of 1122 imprisonment of 20 years, and shall be ordered to pay a fine of 1123 $100,000. 1124 (III)Is 28 grams or more, such person shall be sentenced 1125 to a mandatory minimum term of imprisonment of 25 years, and 1126 shall be ordered to pay a fine of $500,000. 1127 c.A person 18 years of age or older who violates sub 1128 subparagraph a. by knowingly selling or delivering to a minor at 1129 least 4 grams of a substance or mixture listed in sub 1130 subparagraph a. shall be sentenced to a mandatory minimum term 1131 of not less than 25 years and not exceeding life imprisonment, 1132 and shall be ordered to pay a fine of $1 million if the 1133 substance or mixture listed in sub-subparagraph a. is in a form 1134 that resembles, or is mixed, granulated, absorbed, spray-dried, 1135 or aerosolized as or onto, coated on, in whole or in part, or 1136 solubilized with or into, a product, when such product or its 1137 packaging further has at least one of the following attributes: 1138 (I)Resembles the trade dress of a branded food product, 1139 consumer food product, or logo food product; 1140 (II)Incorporates an actual or fake registered copyright, 1141 service mark, or trademark; 1142 (III)Resembles candy, cereal, a gummy, a vitamin, or a 1143 chewable product, such as a gum or gelatin-based product; or 1144 (IV)Contains a cartoon character imprint. 1145 5.A person who knowingly sells, purchases, manufactures, 1146 delivers, or brings into this state, or who is knowingly in 1147 actual or constructive possession of, 30 kilograms or more of 1148 any morphine, opium, oxycodone, hydrocodone, codeine, 1149 hydromorphone, or any salt, derivative, isomer, or salt of an 1150 isomer thereof, including heroin, as described in s. 1151 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or 1152 more of any mixture containing any such substance, commits the 1153 first degree felony of trafficking in illegal drugs. A person 1154 who has been convicted of the first degree felony of trafficking 1155 in illegal drugs under this subparagraph shall be punished by 1156 life imprisonment and is ineligible for any form of 1157 discretionary early release except pardon or executive clemency 1158 or conditional medical release under s. 947.149. However, if the 1159 court determines that, in addition to committing any act 1160 specified in this paragraph: 1161 a.The person intentionally killed an individual or 1162 counseled, commanded, induced, procured, or caused the 1163 intentional killing of an individual and such killing was the 1164 result; or 1165 b.The persons conduct in committing that act led to a 1166 natural, though not inevitable, lethal result, 1167 1168 such person commits the capital felony of trafficking in illegal 1169 drugs, punishable as provided in ss. 775.082 and 921.142. A 1170 person sentenced for a capital felony under this paragraph shall 1171 also be sentenced to pay the maximum fine provided under 1172 subparagraph 1. 1173 6.A person who knowingly brings into this state 60 1174 kilograms or more of any morphine, opium, oxycodone, 1175 hydrocodone, codeine, hydromorphone, or any salt, derivative, 1176 isomer, or salt of an isomer thereof, including heroin, as 1177 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 1178 60 kilograms or more of any mixture containing any such 1179 substance, and who knows that the probable result of such 1180 importation would be the death of a person, commits capital 1181 importation of illegal drugs, a capital felony punishable as 1182 provided in ss. 775.082 and 921.142. A person sentenced for a 1183 capital felony under this paragraph shall also be sentenced to 1184 pay the maximum fine provided under subparagraph 1. 1185 7.A person who knowingly sells, purchases, manufactures, 1186 delivers, or brings into this state, or who is knowingly in 1187 actual or constructive possession of, 4 grams or more of 1188 xylazine, as described in s. 893.03(1)(c)37., or any salt 1189 thereof, or 4 grams or more of any mixture containing any such 1190 substance, commits a felony of the first degree, which felony 1191 shall be known as trafficking in xylazine, punishable as 1192 provided in s. 775.082, s. 775.083, or s. 775.084. If the 1193 quantity involved: 1194 a.Is 4 grams or more, but less than 14 grams, such person 1195 shall be sentenced to a mandatory minimum term of imprisonment 1196 of 7 years and shall be ordered to pay a fine of $50,000. 1197 b.Is 14 grams or more, but less than 28 grams, such person 1198 shall be sentenced to a mandatory minimum term of imprisonment 1199 of 20 years and shall be ordered to pay a fine of $100,000. 1200 c.Is 28 grams or more, such person shall be sentenced to a 1201 mandatory minimum term of imprisonment of 25 years and shall be 1202 ordered to pay a fine of $500,000. 1203 Section 4.This act shall take effect October 1, 2025.